Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.

MLA

Kehm, Rebecca D., et al. “Regular Use of Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs and Breast Cancer Risk for Women at Familial or Genetic Risk: A Cohort Study.” Breast Cancer Research, vol. 21, no. 1, Apr. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13058-019-1135-y.

APA

Kehm, R. D., Hopper, J. L., John, E. M., Phillips, K.-A., MacInnis, R. J., Dite, G. S., Milne, R. L., Liao, Y., Zeinomar, N., Knight, J. A., Southey, M. C., Vahdat, L., Kornhauser, N., Cigler, T., Chung, W. K., Giles, G. G., McLachlan, S.-A., Friedlander, M. L., Weideman, P. C., & Glendon, G. (2019). Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Research, 21(1), N.PAG. https://doi.org/10.1186/s13058-019-1135-y

Chicago

Kehm, Rebecca D., John L. Hopper, Esther M. John, Kelly-Anne Phillips, Robert J. MacInnis, Gillian S. Dite, Roger L. Milne, et al. 2019. “Regular Use of Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs and Breast Cancer Risk for Women at Familial or Genetic Risk: A Cohort Study.” Breast Cancer Research 21 (1): N.PAG. doi:10.1186/s13058-019-1135-y.